Dr. Wendy Naimark is CTO and co-founder of Toronto based Ripple Therapeutics, a clinical stage ophthalmology company. A material scientist by training, Dr. Naimark’s career has focused on the development of local drug delivery products across a broad range of pharma and medtech applications. Wendy has been leading teams both large and small company settings for over 20 years. Dr. Naimark is an inventor of 35 patents in the local drug delivery field.